1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bray, D; Garzon-Muvdi, T; Ioachimescu, A; Maldonado, J; Mayol, M; Medina, EJ; Morales, B; Neill, S; Porto, E; Pradilla, G; Read, W; Revuelta Barbero, JM; Rodas, A; Zohdy, YM | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
Topics: Humans; Indazoles; Male; Middle Aged; Pituitary Neoplasms; POU Domain Factors; Prolactinoma | 2023 |